Similar articles

• Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.

  Levey AS, Gansevoort RT, Coresh J, Inker LA, Heerspink HL, Grams ME, Greene T, Tighiouart H, Matsushita K, Ballew SH, Sang Y, Vonesh E, Ying J, Manley T, de Zeeuw D, Eckardt KU, Levin A, Perkovic V, Zhang L, Willis K. Levey AS, et al. Am J Kidney Dis. 2020 Jan;75(1):84-104. doi: 10.1053/j.ajkd.2019.06.009. Epub 2019 Aug 28. Am J Kidney Dis. 2020. PMID: 31473020
• Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials: A Review.

  Khan MS, Bakris GL, Shahid I, Weir MR, Butler J. Khan MS, et al. JAMA Cardiol. 2022 May 1;7(5):549-555. doi: 10.1001/jamacardio.2021.5151. JAMA Cardiol. 2022. PMID: 34985495 Review.
• Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study.

  Greene T, Teng CC, Inker LA, Redd A, Ying J, Woodward M, Coresh J, Levey AS. Greene T, et al. Am J Kidney Dis. 2014 Dec;64(6):867-79. doi: 10.1053/j.ajkd.2014.08.019. Epub 2014 Oct 31. Am J Kidney Dis. 2014. PMID: 25441440
• Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials.

  Badve SV, Palmer SC, Hawley CM, Pascoe EM, Strippoli GF, Johnson DW. Badve SV, et al. Nephrol Dial Transplant. 2016 Sep;31(9):1425-36. doi: 10.1093/ndt/gfv269. Epub 2015 Jul 11. Nephrol Dial Transplant. 2016. PMID: 26163881 Review.
• Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.

  Kanda E, Usui T, Kashihara N, Iseki C, Iseki K, Nangaku M. Kanda E, et al. Clin Exp Nephrol. 2018 Apr;22(2):318-327. doi: 10.1007/s10157-017-1463-0. Epub 2017 Sep 7. Clin Exp Nephrol. 2018. PMID: 28884361 Free PMC article.